Advanced NanoTherapies

Los Gatos, United States Founded: 2018 • Age: 8 yrs
Developer of a drug delivery device for cardiac vascular diseases
Request Access

About Advanced NanoTherapies

Advanced NanoTherapies is a company based in Los Gatos (United States) founded in 2018 by Mehdi Shishehbor, Philippe Urbain, and Marwan Berrada.. Advanced NanoTherapies has raised $26.38 million across 4 funding rounds from investors including Cleveland Clinic and ForMED Ventures. Advanced NanoTherapies offers products and services including SirPlux™ Duo Drug Coated Balloon. Advanced NanoTherapies operates in a competitive market with competitors including Sirnaomics, Liquidia, Acorda, Genedit and NanoSyrinx, among others.

  • Headquarter Los Gatos, United States
  • Founders Mehdi Shishehbor, Philippe Urbain, Marwan Berrada
  • Sectors
    Technology
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Advanced Nanotherapies Inc.
Operational Areas
Technology → Quantum & Emerging Technologies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $26.38 M (USD)

    in 4 rounds

  • Latest Funding Round
    $4 M (USD), Series A

    Aug 22, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Advanced NanoTherapies

Advanced NanoTherapies offers a comprehensive portfolio of products and services, including SirPlux™ Duo Drug Coated Balloon. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Delivers two drugs to prevent artery restenosis with sustained release.

Funding Insights of Advanced NanoTherapies

Advanced NanoTherapies has successfully raised a total of $26.38M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $4.0M
  • First Round

    (13 Oct 2020)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Series A - Advanced NanoTherapies Valuation

investors

Aug, 2022 Amount Series A - Advanced NanoTherapies Valuation

investors

Jun, 2022 Amount Series A - Advanced NanoTherapies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Advanced NanoTherapies

Advanced NanoTherapies has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Cleveland Clinic and ForMED Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Healthcare services are provided by a leading academic medical center.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Advanced NanoTherapies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Advanced NanoTherapies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Advanced Nanotherapies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Advanced NanoTherapies

Advanced NanoTherapies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Liquidia, Acorda, Genedit and NanoSyrinx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
RNA-based therapeutics for cancer and fibrosis are developed.
domain founded_year HQ Location
Engineered particles & films for life and material sciences applications
domain founded_year HQ Location
Engaged in the development and commercialization of therapies that improve neurological function.
domain founded_year HQ Location
Genetic medicines are delivered using polymer nanoparticle platforms.
domain founded_year HQ Location
Drug delivery systems to cell interiors are developed via nanosyringes.
domain founded_year HQ Location
Drug delivery solutions via single-walled carbon nanotubes are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Advanced Nanotherapies

Frequently Asked Questions about Advanced NanoTherapies

When was Advanced NanoTherapies founded?

Advanced NanoTherapies was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is Advanced NanoTherapies located?

Advanced NanoTherapies is headquartered in Los Gatos, United States. It is registered at Los Gatos, California, United States.

Who is the current CEO of Advanced NanoTherapies?

Marwan Berrada is the current CEO of Advanced NanoTherapies. They have also founded this company.

Is Advanced NanoTherapies a funded company?

Advanced NanoTherapies is a funded company, having raised a total of $26.38M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7.2M, raised on Oct 13, 2020.

What does Advanced NanoTherapies do?

Developer of a drug delivery device for cardiac vascular diseases. It offers SirPlux Duo Drug-Coated Balloon based on nanoparticle technology for sustained drug release to treat coronary artery disease.

Who are the top competitors of Advanced NanoTherapies?

Advanced NanoTherapies's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.

What products or services does Advanced NanoTherapies offer?

Advanced NanoTherapies offers SirPlux™ Duo Drug Coated Balloon.

Who are Advanced NanoTherapies's investors?

Advanced NanoTherapies has 2 investors. Key investors include Cleveland Clinic, and ForMED Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available